DE60331724D1 - Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren - Google Patents
Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäurenInfo
- Publication number
- DE60331724D1 DE60331724D1 DE60331724T DE60331724T DE60331724D1 DE 60331724 D1 DE60331724 D1 DE 60331724D1 DE 60331724 T DE60331724 T DE 60331724T DE 60331724 T DE60331724 T DE 60331724T DE 60331724 D1 DE60331724 D1 DE 60331724D1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- bisphosphonic acids
- certain solvents
- acid
- diluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38128402P | 2002-05-17 | 2002-05-17 | |
US40131302P | 2002-08-06 | 2002-08-06 | |
US42333702P | 2002-11-01 | 2002-11-01 | |
US43183802P | 2002-12-09 | 2002-12-09 | |
US45019303P | 2003-02-25 | 2003-02-25 | |
PCT/US2003/015676 WO2003097655A1 (en) | 2002-05-17 | 2003-05-19 | Use of certain diluents for making bisphosphonic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60331724D1 true DE60331724D1 (de) | 2010-04-29 |
Family
ID=29554537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60331724T Expired - Fee Related DE60331724D1 (de) | 2002-05-17 | 2003-05-19 | Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren |
Country Status (12)
Country | Link |
---|---|
US (3) | US7038083B2 (de) |
EP (1) | EP1476451B1 (de) |
JP (1) | JP3857706B2 (de) |
KR (1) | KR100681282B1 (de) |
CN (1) | CN1665825A (de) |
AT (1) | ATE461205T1 (de) |
AU (1) | AU2003233569A1 (de) |
CA (2) | CA2485443C (de) |
DE (1) | DE60331724D1 (de) |
IL (1) | IL165227A0 (de) |
PL (1) | PL373574A1 (de) |
WO (1) | WO2003097655A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2470495A1 (en) * | 2001-12-24 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
AU2003233569A1 (en) * | 2002-05-17 | 2003-12-02 | Teva Pharmaceutical Industries Ltd. | Use of certain diluents for making bisphosphonic acids |
EP1656386B1 (de) | 2003-08-21 | 2009-12-09 | Sun Pharmaceuticals Industries Ltd. | Verfahren zur herstellung von bisphosphonsäureverbindungen |
ATE508134T1 (de) * | 2003-12-23 | 2011-05-15 | Alchymars S P A | Amorphe form das natriumsalzes der ibandronsäure |
WO2005063717A1 (en) * | 2003-12-26 | 2005-07-14 | Natco Pharma Limited | An improved process for the preparation of zoledronic acid |
MX2007000087A (es) * | 2004-06-23 | 2007-11-06 | Teva Pharma | Acido ibandronico solido y cristalino. |
EP1802641B8 (de) | 2004-10-08 | 2012-03-07 | The Board Of Trustees Of The University Of Illinois | Bisphosphonatverbindungen und -verfahren für knochenschwundkrankheiten, krebs, knochenschmerzen, immunstörungen und infektionskrankheiten |
WO2007109585A2 (en) | 2006-03-17 | 2007-09-27 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods |
US8012949B2 (en) | 2004-10-08 | 2011-09-06 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS |
US7214818B2 (en) | 2004-10-29 | 2007-05-08 | Hoffmann-La Roche Inc. | Method for synthesizing bisphosphonate |
PL199215B1 (pl) * | 2004-12-28 | 2008-08-29 | Politechnika Gdanska | Sposób wytwarzania kwasu [1-hydroksy-2-(3-pirydylo)etylidenobisfosfonowego] oraz jego soli monosodowej dwu i pół wodnej |
EP1891081B1 (de) * | 2005-06-13 | 2014-08-20 | Jubilant Organosys Limited | Verfahren zur herstellung von bisphosphonsäuren und formen davon |
US8003820B2 (en) | 2005-10-20 | 2011-08-23 | Dr. Reddy's Laboratories Limited | Process for preparing bisphosphonic acids |
WO2007069049A2 (en) * | 2005-12-16 | 2007-06-21 | Wockhardt Ltd | Processes for the preparation of pure zoledronic acid |
WO2007083240A2 (en) | 2006-01-20 | 2007-07-26 | Aurobindo Pharma Limited | An improved process for the preparation of bisphosphonic acids |
CN101421284A (zh) * | 2006-04-25 | 2009-04-29 | 特瓦制药工业有限公司 | 伊班膦酸的结晶形式和其制备方法 |
WO2007125521A2 (en) * | 2006-05-02 | 2007-11-08 | Ranbaxy Laboratories Limited | Polymorphic form of zoledronic acid and processes for their preparation |
JP5354858B2 (ja) * | 2006-05-09 | 2013-11-27 | 株式会社Adeka | スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物 |
US8076483B2 (en) * | 2006-05-11 | 2011-12-13 | M/S. Ind Swift Laboratories Limited | Process for the preparation of pure risedronic acid or salts |
WO2008044245A2 (en) * | 2006-10-10 | 2008-04-17 | Matrix Laboratories Ltd | A process for the preparation of risedronate sodium hemipentahydrate |
CA2570949A1 (en) * | 2006-12-12 | 2008-06-12 | Apotex Pharmachem Inc. | Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
KR101150662B1 (ko) * | 2007-04-11 | 2012-05-29 | 에프. 호프만-라 로슈 아게 | 이반드로네이트의 다단계 합성 |
US7605148B2 (en) * | 2007-04-16 | 2009-10-20 | Aurobindo Pharma Ltd. | Aqueous oral solution of bisphosphonic acid |
US20100317859A1 (en) * | 2007-05-16 | 2010-12-16 | Actavis Group Ptc Ehf | Process for the Preparation of Risedronate Sodium |
WO2009050731A2 (en) * | 2007-06-20 | 2009-04-23 | Alkem Laboratories Ltd | Novel process for preparing risedronic acid |
KR100877667B1 (ko) | 2007-06-28 | 2009-01-08 | 보령제약 주식회사 | 리세드로네이트의 제조 방법 |
WO2009034580A1 (en) * | 2007-09-11 | 2009-03-19 | Fleming Laboratories Limited | Improved process for the preparation of risedronate sodium hemipentahydrate |
JP5258370B2 (ja) * | 2008-05-08 | 2013-08-07 | ダイト株式会社 | リセドロン酸の工業的製造方法 |
CN102124016A (zh) * | 2008-07-11 | 2011-07-13 | 斯索恩有限公司 | 制备1-羟基亚烷基-1,1-双膦酸的方法 |
PL213599B1 (pl) * | 2008-10-31 | 2013-03-29 | Politechnika Gdanska | Sposób otrzymywania kwasu [1-hydroksy-2-(1H-imidazol-1-ilo)-etylideno] bisfosfonowego |
WO2010060619A1 (en) * | 2008-11-26 | 2010-06-03 | Synthon B.V. | Process for making zoledronic acid |
EP2192126B1 (de) | 2008-11-26 | 2013-03-27 | Synthon B.V. | Verfahren zur Herstellung von Zoledronsäure |
US20100130746A1 (en) * | 2008-11-26 | 2010-05-27 | Martin Kas | Process for Making Zoledronic Acid |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
PT2459176T (pt) | 2009-07-31 | 2017-12-11 | Gruenenthal Gmbh | Método de cristalização e biodisponibilidade |
WO2011016738A1 (en) | 2009-08-05 | 2011-02-10 | Zaklady Farmaceutyczne Polpharma Sa | A process for the synthesis of 1-hydroxy-3-(n-methylpentylamino) propylidene bisphosphonic acid monosodium salt, monohydrate |
WO2011023280A1 (en) | 2009-08-28 | 2011-03-03 | Synthon B.V. | Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids |
US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
EP3553067A1 (de) * | 2018-04-10 | 2019-10-16 | Abiogen Pharma S.p.A. | Polymorph von natriumneridronat und herstellungsverfahren dafür |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
IT1201087B (it) * | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
IT1196315B (it) * | 1984-10-29 | 1988-11-16 | Gentili Ist Spa | Procedimento per la preparazione di acidi difosfonici |
DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
DE3700772A1 (de) | 1987-01-13 | 1988-07-21 | Inst Khim Kinetiki I Gorenija | Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen |
US4922007A (en) | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
US5019651A (en) | 1990-06-20 | 1991-05-28 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof |
US5159108A (en) * | 1990-09-18 | 1992-10-27 | Merck & Co., Inc. | Process for preparing an antihypercalcemic agent |
US5039819A (en) * | 1990-09-18 | 1991-08-13 | Merck & Co., Inc. | Diphosphonate intermediate for preparing an antihypercalcemic agent |
US5327490A (en) * | 1991-02-19 | 1994-07-05 | Intervoice, Inc. | System and method for controlling call placement rate for telephone communication systems |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
TW257765B (de) * | 1993-08-25 | 1995-09-21 | Merck & Co Inc | |
US5510517A (en) * | 1993-08-25 | 1996-04-23 | Merck & Co., Inc. | Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids |
US5449819A (en) * | 1994-06-06 | 1995-09-12 | Merck & Co., Inc. | Process for removing waste pox, alendronate and its by products |
US5589691A (en) * | 1994-06-06 | 1996-12-31 | Merck & Co., Inc. | Process for recovery and recycle of methanesulfonic acid and phosphorous acid |
JP3349032B2 (ja) * | 1996-03-15 | 2002-11-20 | 株式会社東芝 | 発呼制御方法 |
KR100192215B1 (ko) | 1996-09-03 | 1999-06-15 | 강재헌 | 3-아미노-1-히드록시프로판-1,1-디포스폰산의 제조방법 |
CA2197267C (en) | 1997-02-11 | 2000-02-08 | Yong Tao | Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
ES2153794B1 (es) * | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
US6562974B2 (en) | 2000-02-01 | 2003-05-13 | The Procter & Gamble Company | Process for making geminal bisphosphonates |
TR200101250A2 (tr) * | 2001-05-10 | 2003-04-21 | E�S Eczaciba�I �Zg�N K�Myasal �R�Nler Sanay� A.�. | 4-amino-1-hidroksibutiliden-1,1-bifosfonik asit veya tuzlarının hazırlanmasına ilişkin proses |
GB0115824D0 (en) * | 2001-06-28 | 2001-08-22 | Rhodia Cons Spec Ltd | Improved solvent systems |
US6645974B2 (en) * | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
ITMI20020908A1 (it) * | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
AU2003233569A1 (en) * | 2002-05-17 | 2003-12-02 | Teva Pharmaceutical Industries Ltd. | Use of certain diluents for making bisphosphonic acids |
HUP0300227A2 (hu) * | 2003-01-28 | 2004-09-28 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására |
EP1656386B1 (de) * | 2003-08-21 | 2009-12-09 | Sun Pharmaceuticals Industries Ltd. | Verfahren zur herstellung von bisphosphonsäureverbindungen |
ATE508134T1 (de) * | 2003-12-23 | 2011-05-15 | Alchymars S P A | Amorphe form das natriumsalzes der ibandronsäure |
US7361761B2 (en) * | 2004-09-28 | 2008-04-22 | Orchid Chemicals & Pharmaceuticals Ltd. | Process for the preparation of bisphosphonic acid |
US8003820B2 (en) * | 2005-10-20 | 2011-08-23 | Dr. Reddy's Laboratories Limited | Process for preparing bisphosphonic acids |
ES2323728T3 (es) * | 2005-12-27 | 2009-07-23 | Ipca Laboratories Limited | Proceso mejorado para la fabricacion de 4-amino-hidroxibutilideno-1,1-bisfosfonico y sus sales. |
WO2007083240A2 (en) * | 2006-01-20 | 2007-07-26 | Aurobindo Pharma Limited | An improved process for the preparation of bisphosphonic acids |
CA2642321A1 (en) * | 2006-02-20 | 2007-08-30 | Alembic Limited | An improved process for the preparation of biphosphonic derivatives |
-
2003
- 2003-05-19 AU AU2003233569A patent/AU2003233569A1/en not_active Abandoned
- 2003-05-19 AT AT03729005T patent/ATE461205T1/de not_active IP Right Cessation
- 2003-05-19 WO PCT/US2003/015676 patent/WO2003097655A1/en active Application Filing
- 2003-05-19 DE DE60331724T patent/DE60331724D1/de not_active Expired - Fee Related
- 2003-05-19 IL IL16522703A patent/IL165227A0/xx unknown
- 2003-05-19 PL PL03373574A patent/PL373574A1/xx not_active Application Discontinuation
- 2003-05-19 KR KR1020047018564A patent/KR100681282B1/ko not_active IP Right Cessation
- 2003-05-19 CA CA2485443A patent/CA2485443C/en not_active Expired - Fee Related
- 2003-05-19 CN CN038160226A patent/CN1665825A/zh active Pending
- 2003-05-19 US US10/442,001 patent/US7038083B2/en not_active Expired - Fee Related
- 2003-05-19 EP EP03729005A patent/EP1476451B1/de not_active Expired - Lifetime
- 2003-05-19 JP JP2004505386A patent/JP3857706B2/ja not_active Expired - Lifetime
- 2003-05-19 CA CA002657002A patent/CA2657002A1/en not_active Abandoned
-
2006
- 2006-02-08 US US11/350,462 patent/US20060128960A1/en not_active Abandoned
-
2009
- 2009-02-10 US US12/368,805 patent/US20090209763A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003097655A1 (en) | 2003-11-27 |
CA2657002A1 (en) | 2003-11-27 |
US20060128960A1 (en) | 2006-06-15 |
KR100681282B1 (ko) | 2007-02-12 |
AU2003233569A1 (en) | 2003-12-02 |
EP1476451A1 (de) | 2004-11-17 |
CA2485443A1 (en) | 2003-11-27 |
PL373574A1 (en) | 2005-09-05 |
EP1476451B1 (de) | 2010-03-17 |
CA2485443C (en) | 2010-04-06 |
IL165227A0 (en) | 2005-12-18 |
US20040043967A1 (en) | 2004-03-04 |
KR20040111633A (ko) | 2004-12-31 |
JP3857706B2 (ja) | 2006-12-13 |
US20090209763A1 (en) | 2009-08-20 |
CN1665825A (zh) | 2005-09-07 |
US7038083B2 (en) | 2006-05-02 |
ATE461205T1 (de) | 2010-04-15 |
JP2005526140A (ja) | 2005-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60331724D1 (de) | Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren | |
ATE451380T1 (de) | Verfahren zur herstellung von bisphosphonsäureverbindungen | |
DE60210772D1 (de) | Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen der familie enterobacteriaceae | |
TW200626951A (en) | Process for modifying offset voltage characteristics of an interferometric modulator | |
ATE510838T1 (de) | Verfahren zur herstellung von 2-methyl-1-(2- methylpropyl)-1h-imidazoä4,5-cüä1,5ünaphthyridi - 4-amin | |
ATE506356T1 (de) | Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen | |
DE60207328D1 (de) | Verfahren zur Herstellung von Phosphorsäureestern | |
DE60329640D1 (de) | Verfahren zur Herstellung von N-Monoalkyl-Beta-Aminoalkoholen | |
ATE310718T1 (de) | Verfahren zur herstellung von (meth)acrylsäureanhydrid | |
ATE366045T1 (de) | Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen | |
DE60300861D1 (de) | Verfahren zur herstellung von siliconverbindungen | |
DE60124289D1 (de) | Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op) | |
DE50005649D1 (de) | Verfahren zur Herstellung von Alkylphosphonsäuren | |
ATE270275T1 (de) | Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren | |
DE50200809D1 (de) | Verfahren zur herstellung von n-phosphonomethyliminodiessigsäure | |
DE50209620D1 (de) | Verfahren zur Herstellung von kristallinem Cholinascorbat | |
DE60211695D1 (de) | Verfahren zur herstellung von phosphorsäureestern | |
ATE389010T1 (de) | Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten | |
ATE428116T1 (de) | Verfahren zur identifizierung wahrend der apoptose modifizierter proteine | |
DE60232878D1 (de) | Unter biokompatiblen bedingungen verarbeitbare fotoresists zur erzeugung von biomolekül-mustern | |
DE502004009156D1 (de) | Verfahren zur herstellung von mit phosphonsäureester modifizierten organosiloxanen | |
DE50109809D1 (de) | Verfahren zur Herstellung von D- oder L-Menthol | |
DE60118247D1 (de) | Magnetfeldofen und betriebsverfahren zur herstellung von bandförmigen dendritischen kristallen | |
DE10290206D2 (de) | Verfahren zur Regelung der Fahrstabilität | |
DE50203388D1 (de) | Verbessertes verfahren zur herstellung von bisphosphiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |